A2A Pharmaceuticals

A2A Pharmaceuticals designs computationally pre-optimized small molecule therapeutics for the treatment of cancer and antibiotic resistant bacterial infections.

Be Part of the Revolution!

Next program starts Winter 2017. Applications due October 30th!